During the last session, Bioceres Crop Solutions Corp (NASDAQ:BIOX)’s traded shares were 1.08 million, with the beta value of the company hitting 0.66. At the end of the trading day, the stock’s price was $4.98, reflecting an intraday gain of 13.18% or $0.58. The 52-week high for the BIOX share is $13.50, that puts it down -171.08 from that peak though still a striking 26.1% gain since the share price plummeted to a 52-week low of $3.68. The company’s market capitalization is $312.30M, and the average trade volume was 275.82K shares over the past three months.
Bioceres Crop Solutions Corp (BIOX) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BIOX has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.1.
Bioceres Crop Solutions Corp (NASDAQ:BIOX) trade information
Bioceres Crop Solutions Corp (BIOX) registered a 13.18% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 13.18% in intraday trading to $4.98, hitting a weekly high. The stock’s 5-day price performance is 18.29%, and it has moved by -27.19% in 30 days. Based on these gigs, the overall price performance for the year is -62.19%.
The consensus price target of analysts on Wall Street is $13, which implies an increase of 61.69% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $12.5 and $13 respectively. As a result, BIOX is trading at a discount of -161.04% off the target high and -151.0% off the low.
Bioceres Crop Solutions Corp (BIOX) estimates and forecasts
In the rating firms’ projections, revenue will decrease -17.74% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 61.87M as predicted by 3 analyst(s). Meanwhile, a consensus of 3 analyst(s) estimates revenue growth to 115.67M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 84M and 124.3M respectively. In this case, analysts expect current quarter sales to shrink by -26.35% and then drop by -6.95% in the coming quarter.
While earnings are projected to return -177.18% in 2025, the next five years will return 89.38% per annum.
BIOX Dividends
Bioceres Crop Solutions Corp is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 1.96 million shares, is of FOURTH SAIL CAPITAL LP’s that is approximately 3.1239% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $21.99 million.
